Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers.
By Jun Fang, Waliul Islam, H. Maeda. Advanced Drug Delivery Reviews, 2020
601 citations recorded by the source corpus.
The enhanced permeability and retention (EPR) effect is a unique phenomenon of solid tumors that is related to their particular anatomical and pathophysiological characteristics, e.g. defective vascular architecture; large gaps between endothelial cells in blood vessels; abundant vascular mediators such as bradykinin, nitric oxide, carbon monoxide, and vascular endothelial growth factor; and impaired lymphatic recovery. These features lead to tumor tissues showing considerable extravasation of plasma components and nanomedicines. These data comprise the basic theory underlying the development of macromolecular agents or nanomedicines. The EPR effect is not necessarily valid for all solid tumors, because tumor blood flow and vascular permeability vary greatly. Tumor blood flow is frequently obstructed as tumor size increases, as often seen clinically; early stage, small tumors show a more uniform EPR effect, whereas advanced large tumor show heterogeneity in EPR effect. Accordingly, it would be very important to apply enhances of EPR effect in clinical setting to make EPR effect more uniform. In this review, we discuss the EPR effect: its history, factors involved, and dynamics and heterogeneity. Strategies to overcome the EPR effect's heterogeneity may guarantee better therapeutic outcomes of drug delivery to advanced cancers.
Subfields: Biomaterials, Biophysics, Materials Chemistry
View Paper: https://www.semanticscholar.org/paper/0477c0cc14485a33da7d2aa211ea784a58b33cb1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Yajun Wang
- T. Gong
- Yongliang Cao
- Yongkai Cao
- Dahua Fan
- Meiqun Cao
Citations in the corpus
- Nanomedicine in cancer therapy (2023, background): “28,29,60 Angiotensin-II is a potent vasoconstrictor that can increase blood pressure via constricting vascular smooth muscle and narrowing blood vessels in normal tissues.”